Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,211 | 330 | 99.3% |
| Education | $37.17 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $786.68 | 51 | $0 (2024) |
| Lilly USA, LLC | $543.07 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $534.76 | 38 | $0 (2024) |
| Novo Nordisk Inc | $407.11 | 26 | $0 (2024) |
| PFIZER INC. | $400.11 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $347.59 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $244.76 | 13 | $0 (2024) |
| Amgen Inc. | $229.28 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $178.57 | 10 | $0 (2023) |
| Abbott Laboratories | $153.29 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $800.78 | 38 | AstraZeneca Pharmaceuticals LP ($153.35) |
| 2023 | $1,002 | 60 | Lilly USA, LLC ($153.66) |
| 2022 | $1,042 | 62 | ABBVIE INC. ($247.13) |
| 2021 | $1,115 | 76 | AbbVie Inc. ($276.51) |
| 2020 | $708.13 | 53 | Lilly USA, LLC ($147.33) |
| 2019 | $229.55 | 17 | Takeda Pharmaceuticals U.S.A., Inc. ($72.20) |
| 2018 | $100.35 | 7 | Novo Nordisk Inc ($27.20) |
| 2017 | $249.69 | 20 | GlaxoSmithKline, LLC. ($111.90) |
All Payment Transactions
333 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: PAIN | ||||||
| 11/12/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $21.91 | General |
| Category: Insulin Pump | ||||||
| 10/29/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.12 | General |
| Category: Insulin Pump | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Oncology | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Biological | ||||||
| 08/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Inflammation | ||||||
| 08/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Hepatitis B Vaccine | ||||||
| 06/25/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: WOMENS HEALTH | ||||||
| 06/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Oncology | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Inflammation | ||||||
| 05/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $35.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: RESPIRATORY | ||||||
| 04/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 902 | 1,337 | $245,914 | $82,584 |
| 2022 | 12 | 813 | 1,147 | $216,388 | $69,362 |
| 2021 | 8 | 656 | 1,011 | $179,560 | $58,445 |
| 2020 | 11 | 713 | 1,033 | $131,199 | $47,696 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 254 | 551 | $94,772 | $30,181 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 125 | 125 | $34,250 | $14,926 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 189 | $48,006 | $14,460 | 30.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $14,564 | $6,180 | 42.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 62 | 62 | $10,292 | $4,608 | 44.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 26 | $10,010 | $3,855 | 38.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 36 | 48 | $10,368 | $1,899 | 18.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 67 | 67 | $2,479 | $1,888 | 76.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,290 | $1,357 | 31.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 28 | 33 | $6,600 | $1,067 | 16.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 28 | $1,036 | $800.80 | 77.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 41 | 61 | $4,880 | $580.72 | 11.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 25 | 25 | $1,050 | $417.50 | 39.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 41 | 73 | $2,117 | $248.93 | 11.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $1,200 | $115.94 | 9.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 405 | $69,660 | $22,155 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 230 | $58,420 | $18,304 | 31.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 101 | 101 | $27,674 | $12,324 | 44.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 99 | 144 | $31,104 | $6,550 | 21.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $6,540 | $2,474 | 37.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 56 | 56 | $4,577 | $2,361 | 51.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $3,990 | $1,726 | 43.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 57 | 57 | $2,109 | $1,537 | 72.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $3,773 | $832.44 | 22.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 40 | 59 | $4,720 | $565.40 | 12.0% |
About Dr. Christopher Combs, MD
Dr. Christopher Combs, MD is a Internal Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679604441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Combs, MD has received a total of $5,249 in payments from pharmaceutical and medical device companies, with $800.78 received in 2024. These payments were reported across 333 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($5,211).
As a Medicare-enrolled provider, Combs has provided services to 3,084 Medicare beneficiaries, totaling 4,528 services with total Medicare billing of $258,087. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Louisville, KY
- Active Since 03/07/2007
- Last Updated 08/24/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679604441
Products in Payments
- UBRELVY (Drug) $582.62
- TRELEGY ELLIPTA (Drug) $324.46
- VRAYLAR (Drug) $281.71
- FARXIGA (Drug) $242.16
- MOUNJARO (Drug) $218.88
- Ozempic (Drug) $213.14
- TRINTELLIX (Drug) $172.56
- NURTEC ODT (Drug) $168.33
- ELIQUIS (Drug) $165.99
- JARDIANCE (Drug) $121.81
- ENTRESTO (Drug) $110.57
- TRULICITY (Drug) $109.38
- Aimovig (Biological) $107.47
- SHINGRIX (Biological) $98.40
- FREESTYLE LIBRE 3 (Device) $93.39
- BASAGLAR (Drug) $81.48
- XARELTO (Drug) $79.72
- EMGALITY (Drug) $79.68
- Cologuard Collection Kit (Device) $75.61
- PREMARIN (Drug) $72.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Louisville
Hisham Alrefai, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Matthew Cave, M.d, M.D
Internal Medicine — Payments: $373,716
Dr. Daniel Stewart, M.d, M.D
Internal Medicine — Payments: $284,815
Dr. Jaspreet Grewal, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $262,625
Mohamed Hegazi, Md, MD
Internal Medicine — Payments: $244,885
Dr. Dawn Caster, M.d, M.D
Internal Medicine — Payments: $158,400